CRISPR is a disruptive gene editing methodology that has invigorated the genomics market, taking life science research to another level of innovation. With explosive growth, the technology is not only creating opportunities in genetic engineering but is fueling growth for enabling technologies, such as NGS, PCR, lab automation, microarrays, nucleic acid preparation kits, flow cytometry and high-content analysis/imaging, that play key roles in preparation, transfection and cell identification/confirmation. Gene editing including CRISPR is creating a more than $700 million market opportunity for the preparation and confirmation of samples.

This information was extracted from SDi’s newly published Market Brief entitled “Gene Editing: CRISPR/Cas9 Changes Everything.” If you have any questions about this report, please contact Glenn Cudiamat, vice president of Research Services, at [email protected].